OBSV - オブスイヴァ (ObsEva SA)

OBSVのニュース

   Can you now get a good deal on ObsEva SA’s shares?  2022/12/28 16:40:00 US Post News
ObsEva SA (NASDAQ:OBSV) marked $0.14 per share on Tuesday, down from a previous closing price of $0.15. While ObsEva SA has underperformed by -4.60%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, OBSV fell by -93.44%, with highs and lows ranging from $2.21 to $0.13, whereas […]
   ObsEva SA: ObsEva Announces Dismissal of Moratorium Proceedings  2022/12/19 06:10:00 Finanz Nachrichten
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland - December 19, 2022 - ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commer…
   ObsEva demonstrates compliance with Nasdaq stockholders equity rule  2022/12/14 12:28:30 Seeking Alpha
   OBSV stock falls on plans to raise share capital with new treasury stock (NASDAQ:OBSV)  2022/12/09 12:19:38 Seeking Alpha
ObsEva SA (OBSV) announced Friday that its board decided to increase the share capital through the issuance of newly registered shares in a bid to raise funds. Read the full story here.
   ObsEva SA: ObsEva To Increase Issued Share Capital by Creating Additional Treasury Shares  2022/12/09 06:05:00 Finanz Nachrichten
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland - December 9, 2022 - ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commerc…
   ObsEva to retire $31M in debt and announces $11M debt refinancing  2022/08/01 11:48:46 Seeking Alpha
   ObsEva SA: ObsEva Announces $31 million Debt Retirement and $11 million Debt Refinancing  2022/08/01 11:05:00 Finanz Nachrichten
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland - August 1, 2022 - ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing novel therapi…
   Canaccord Genuity Downgrades ObsEva to Hold  2022/07/29 18:54:02 Investing.com
https://www.investing.com/news/pro/canaccord-genuity-downgrades-obseva-to-hold-432SI-2858488
   UPDATE: Cantor Fitzgerald Downgrades ObsEva to Neutral  2022/07/28 17:14:01 Investing.com
https://www.investing.com/news/pro/update-cantor-fitzgerald-downgrades-obseva-to-neutral-432SI-2857141
   US stock market closes higher, Dow Jones gains 1.37%  2022/07/28 03:13:14 InstaForex
At the close of the New York Stock Exchange, the Dow Jones rose 1.37% to hit a monthly high, the S&P 500 rose 2.62% and the NASDAQ Composite rose 4.06%. Shares of Microsoft Corporation led the way among the components of the Dow Jones index in today''s trading, which gained 16.84 points (6.69%) to close at 268.74. Salesforce.com Inc rose 9.84 points or 5.77% to close at 180.30. Walmart Inc rose 4.61 points or 3.78% to close at 126.59. The biggest losers were 3M Company, which shed 1.89 points or 1.34% to end the session at 138.86. The Travelers Companies Inc was up 1.90 points or 1.18% to close at 158.96, while Visa Inc Class A was down 2.02 points or 0.95% to close at mark 210.47. Leading gainers among the components of the S&P 500 in today''s trading were Enphase Energy Inc, which rose 17.89% to hit 254.77, Chipotle Mexican Grill Inc, which gained 14.70% to close at 1.00. as well as PayPal Holdings Inc, which rose 12.18% to end the session at 86.42. The biggest losers were Sherwin-Williams Co, which shed 8.78% to close at 231.97.
   Wining stocks: ObsEva SA (NASDAQ:OBSV 2.59%), COMSovereign Holding Corp. (NASDAQ:COMS -3.60%)  2021/11/05 00:16:45 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Wining stocks: ObsEva SA (NASDAQ:OBSV 2.59%), COMSovereign Holding Corp. (NASDAQ:COMS -3.60%) appeared first on Stocks Equity .
   ObsEva EPS beats by $0.23  2021/11/04 06:18:32 Seeking Alpha
   ObsEva SA: ObsEva Announces Third Quarter 2021 Financial Results and Business Update  2021/11/04 06:05:00 FinanzNachrichten
-Linzagolix for uterine fibroids: Pending regulatory approval in the US and Europe with commercial planning efforts underway- -Linzagolix for endometriosis: Readout from Phase 3 EDELWEISS 3 study
   ObsEva Announces Third Quarter 2021 Financial Results and Business Update  2021/11/04 06:00:00 Intrado Digital Media
- Linzagolix f or uterine fibroids: Pending regulatory approval in the US and Europe with commercial planning efforts underway -
   ObsEva Announces Management Change  2021/10/29 20:30:00 Intrado Digital Media
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange

calendar